GPOs tout savings
This article was originally published in The Gray Sheet
Executive Summary
A Group Purchasing Organization industry-sponsored study reports that GPO-negotiated prices save U.S. hospitals and other types of health systems $36 billion annually, including $1.9 billion in the cardiac implant space, $840 million in orthopedic implants, $8.5 billion from non-physician preference item medical/surgical equipment and $6.8 billion for hospital pharmaceutical purchases. The remainder of the savings comes from contracts for miscellaneous products and services, including computers, food and janitorial services
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.